Volume 3, Issue 2: European Association for the Study of the Liver (EASL) (/HCV Update) [PODCAST]
e-ViralHepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 3, Issue 2)
Nurses and health care professionals involved in the care of patients with Hepatitis.
After participating in this activity, the participant will demonstrate the ability to:
- Summarize the evidence describing newly emerging therapies for hepatitis C
- Assess how these newly emerging therapies may affect therapeutic decision-making in patients with HCV genotype 3
- Assess how these new therapies may affect therapeutic decision-making in patients with HCV genotype 1
Mark S. Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Divisions of Infectious Disease and Gastroenterology/Hepatology
The Johns Hopkins University School of Medicine
- 0.50 ANCC